Jeffrey N. Martin

Jessie K. Edwards, Richard D Moore, S. Cole, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2021, medRxiv.

Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals

Jeffrey N. Martin, D. Glidden, A. Bolger, 2015, PloS one.

Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?

Jeffrey N. Martin, P. Harrigan, M. Siedner, 2017, Journal of acquired immune deficiency syndromes.

Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease

Jeff E. Mold, P. Loke, Jeffrey N. Martin, 2010, Science Translational Medicine.

HIV-1 Genomes Are Enriched in Memory CD4+ T-Cells with Short Half-Lives

Jeffrey N. Martin, F. Hecht, J. McCune, 2021, mBio.

Gag-Positive Reservoir Cells Are Susceptible to HIV-Specific Cytotoxic T Lymphocyte Mediated Clearance In Vitro and Can Be Detected In Vivo

Jeffrey N. Martin, S. Migueles, M. Connors, 2013, PloS one.

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Peter Hunt, Lea Liu, J. Kahn, 2004, Blood.

Prospective Study of the Mental Health Consequences of Sexual Violence Among Women Living With HIV in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2016, Journal of interpersonal violence.

Relationship Power and Sexual Violence Among HIV-Positive Women in Rural Uganda

Amy A. Conroy, Jeffrey N. Martin, D. Bangsberg, 2016, AIDS and Behavior.

Sexual Relationship Power and Malnutrition Among HIV-Positive Women in Rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2012, AIDS and Behavior.

The social context of food insecurity among persons living with HIV/AIDS in rural Uganda.

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2011, Social science & medicine.

Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses

Christos J. Petropoulos, Terri Wrin, Steven G. Deeks, 2006, Journal of Virology.

Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda

Jeffrey N. Martin, D. Bangsberg, J. Haberer, 2018, PloS one.

Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach

Nneka Emenyonu, David V Glidden, Elvin H Geng, 2010, Journal of acquired immune deficiency syndromes.

High incidence of intended partner pregnancy among men living with HIV in rural Uganda: Implications for safer conception services.

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2019, Journal of acquired immune deficiency syndromes.

The Dynamic Relationship Between Social Support and HIV-Related Stigma in Rural Uganda

D. Bangsberg, A. Tsai, J. Haberer, 2014, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

Jeffrey N. Martin, P. Ganz, S. Deeks, 2009, AIDS.

Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection

Jeffrey N. Martin, A. Bolger, D. Waters, 2004, Circulation.

The new england journal of medicine Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

J. Goedert, B. Lau, R. Hogg, 2009 .

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

J. Kahn, Jeffrey N. Martin, M. Chesney, 2001, The Journal of infectious diseases.

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

M. Lederman, Jeffrey N. Martin, D. Douek, 2009, The Journal of infectious diseases.

HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses

Rachel E. Owen, Marion C Lanteri, Jeffrey N. Martin, 2010, AIDS.

Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda.

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2012, Social science & medicine.

Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda.

E. Vittinghoff, Jeffrey N. Martin, D. Bangsberg, 2014, Drug and alcohol dependence.

A closer look at hepatitis C clearance in HIV controllers: a response.

Jeffrey N. Martin, M. Busch, S. Deeks, 2014, AIDS.

How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence from a Cohort Study in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2013, AIDS and Behavior.

A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.

C. Yiannoutsos, D. Glidden, D. Bangsberg, 2012, American journal of epidemiology.

Retention in Care among HIV-Infected Patients in Resource-Limited Settings: Emerging Insights and New Directions

C. Yiannoutsos, M. Petersen, Jeffrey N. Martin, 2010, Current HIV/AIDS reports.

National estimates and predictors of prescription medication sample use in the United States, 1999-2005.

E. Vittinghoff, Jeffrey N. Martin, B. Guglielmo, 2010, Journal of the American Pharmacists Association : JAPhA.

Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2014, AIDS.

Contraceptive use following unintended pregnancy among Ugandan women living with HIV

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2018, PloS one.

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers

Jeffrey N. Martin, D. Nixon, F. Hecht, 2017, Retrovirology.

Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014, Retrovirology.

The independent effect of drug resistance on T cell activation in HIV infection

Jeffrey N. Martin, E. Sinclair, D. Bangsberg, 2006, AIDS.

Intracellular Casp8p41 content is inversely associated with CD4 T cell count.

M. Lederman, D. Douek, J. Brenchley, 2010, The Journal of infectious diseases.

Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

James J. Goedert, Sharada P. Modur, Mari M. Kitahata, 2013, PloS one.

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Rebecca Hoh, Peter Bacchetti, Matthew C Strain, 2013, The Journal of infectious diseases.

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy

Jeffrey N. Martin, D. Bangsberg, T. Neilands, 2011, AIDS.

HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control

Steven G. Deeks, Elizabeth Sinclair, Jeffrey N. Martin, 2008, Journal of Virology.

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, The Journal of infectious diseases.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Jeffrey N. Martin, D. Douek, J. Brenchley, 2008, The Journal of infectious diseases.

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.

Jeffrey N. Martin, H. Hatano, F. Hecht, 2013, The Journal of infectious diseases.

Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.

E. Sinclair, L. Corey, M. Jacobson, 2011, The Journal of infectious diseases.

Gut epithelial barrier and systemic inflammation during chronic HIV infection

Jeffrey N. Martin, J. McCune, J. Inadomi, 2015, AIDS.

UC Office of the President Recent Work Title The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD 4 + T cell recovery : a randomized crossover trial

Jeffrey N. Martin, J. Lifson, J. McCune, 2014 .

Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans

J. Mefford, J. Witte, Jeffrey N. Martin, 2016, AIDS.

Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium.

Jeffrey N. Martin, D. Waters, P. Ganz, 2012, The American journal of cardiology.

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, JCI insight.

Markers of Fungal Translocation Are Elevated During Post-Acute Sequelae of SARS-CoV-2 Infection and Induce NF-κB Triggered Inflammation

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, bioRxiv.

Multi-Center Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Promising Activity as Combination Therapy with Manageable Toxicity.

A. Jakubowiak, S. Lonial, Jeffrey N. Martin, 2007 .

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.

Richard D Moore, J. Goedert, B. Lau, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.

R. Siliciano, M. Peluso, Jeffrey N. Martin, 2020, JCI insight.

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Jeffrey N. Martin, E. Sinclair, H. Lampiris, 2003, The Journal of infectious diseases.

Tutorial on Directed Acyclic Graphs.

Jeffrey N. Martin, M. Glymour, J. Digitale, 2021, Journal of clinical epidemiology.

Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.

Marion C Lanteri, Jeffrey N. Martin, P. Borrow, 2014, AIDS research and human retroviruses.

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, Journal of neurovirology.

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population

Richard D Moore, M. Budoff, Jeffrey N. Martin, 2017, Journal of acquired immune deficiency syndromes.

High-Risk Sexual Behavior in Adults With Genotypically Proven Antiretroviral-Resistant HIV Infection

Jeffrey N. Martin, R. Grant, S. Deeks, 2005, Journal of acquired immune deficiency syndromes.

The cure of the 'Berlin patient': why did pre-existing X4-variants not emergence after allogeneic CCR5-Delta 32 SCT?

Jeffrey N. Martin, S. Deeks, L. Vandekerckhove, 2012 .

Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America

B. Chi, C. Yiannoutsos, Jeffrey N. Martin, 2011, PLoS medicine.

Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity

M. Carrington, Jeffrey N. Martin, P. Harrigan, 2018, Journal of Virology.

A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, PloS one.

Biomarker Testing to Estimate Under-Reported Heavy Alcohol Consumption by Persons with HIV Initiating ART in Uganda

Jeffrey N. Martin, D. Bangsberg, M. Javors, 2010, AIDS and Behavior.

Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

M. Peluso, Jeffrey N. Martin, D. Glidden, 2021, The Journal of infectious diseases.

Sexual transmission and the natural history of human herpesvirus 8 infection.

Jeffrey N. Martin, D. Osmond, D. Ganem, 1998, The New England journal of medicine.

Partial treatment interruptions.

Jeffrey N. Martin, S. Deeks, Jeffrey N. Martin, 2007, Current opinion in HIV and AIDS.

Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection

Jeffrey N. Martin, S. Deeks, R. Scherzer, 2020, JAMA network open.

Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy

Jeffrey N. Martin, H. Hatano, E. Delwart, 2008, Journal of Virology.

Geriatric Syndromes in Older HIV-Infected Adults

Jeffrey N. Martin, I. Cenzer, K. Covinsky, 2015, Journal of acquired immune deficiency syndromes.

Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease

G. McVean, M. Carrington, A. Bowcock, 2012, PLoS genetics.

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

David R Bangsberg, Ronald J Bosch, M. Lederman, 2006, JAMA.

Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.

A. Sönnerborg, S. Deeks, J. Andersson, 2013, Blood.

MR1-restricted MAIT-cell population in chronic HIV-1 infection Activation, exhaustion, and persistent decline of the antimicrobial

Jeffrey N. Martin, A. Sönnerborg, S. Deeks, 2013 .

Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients

Jeffrey N. Martin, S. Deeks, R. Scherzer, 2012, AIDS.

Impact of HIV Infection on Diastolic Function and Left Ventricular Mass

Jeffrey N. Martin, A. Bolger, S. Deeks, 2010, Circulation. Heart failure.

Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen.

Wei Huang, Rebecca Hoh, Torsten B Neilands, 2007, The Journal of infectious diseases.

Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.

Eoin Coakley, Rebecca Hoh, Peter Hunt, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid Emergence of Enfuvirtide Resistance in HIV-1-Infected Patients: Results of a Clonal Analysis

Rebecca Hoh, Daniel R Kuritzkes, Jeffrey N. Martin, 2006, Journal of acquired immune deficiency syndromes.

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.

Rebecca Hoh, Torsten B Neilands, Robert M Grant, 2005, The Journal of infectious diseases.

Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility ofHuman Immunodeficiency Virus Type 1 to Other Classes of Entry Inhibitors

Steven G. Deeks, R. Doms, Jeffrey N. Martin, 2007, Journal of Virology.

Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility of Human Immunodeﬁciency Virus Type 1 to Other Classes of Entry Inhibitors (cid:1)

R. Doms, Jeffrey N. Martin, S. Deeks, 2007 .

Transcriptional Errors in Human Immunodeficiency Virus Type 1 Generate Targets for T-Cell Responses

Jeffrey N. Martin, D. Nixon, F. Hecht, 2009, Clinical and Vaccine Immunology.

Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection

Jeffrey N. Martin, D. Nixon, W. Koff, 2012, PloS one.

Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.

M. Lederman, Jeffrey N. Martin, C. Meinert, 2014, The Journal of infectious diseases.

Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2011, Journal of Virology.

Strong Human Endogenous Retrovirus-Speciﬁc T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection (cid:1) †‡

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2011 .

Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia

Z. Grossman, Jeffrey N. Martin, D. Nixon, 2004, AIDS.

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.

Jeffrey N. Martin, S. Deeks, R. Pollard, 2009, Blood.

Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2014, Journal of acquired immune deficiency syndromes.

The Factor Structure and Presentation of Depression Among HIV-Positive Adults in Uganda

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2014, AIDS and Behavior.

Declining Prevalence of Probable Depression Among Patients Presenting for Antiretroviral Therapy in Rural Uganda: The Role of Early Treatment Initiation

Jeffrey N. Martin, A. R. Mocello, D. Bangsberg, 2014, AIDS and Behavior.

Internalized stigma, depressive symptoms, and the modifying role of antiretroviral therapy: A cohort study in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2021, SSM. Mental health.

Reversal of the Kynurenine Pathway of Tryptophan Catabolism May Improve Depression in ART-Treated HIV-Infected Ugandans

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2014, Journal of acquired immune deficiency syndromes.

Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection

Jeffrey N. Martin, P. Ganz, S. Deeks, 2014, AIDS.

ASYMMETRIC DIMETHYLARGININE LEVELS ARE ASSOCIATED WITH PULMONARY ARTERIAL HYPERTENSION IN HIV-INFECTED INDIVIDUALS

Jeffrey N. Martin, P. Ganz, S. Deeks, 2012 .

Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension

Jeffrey N. Martin, S. Deeks, P. Hsue, 2008, AIDS.

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

J. Kahn, Jeffrey N. Martin, F. Hecht, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa

Jeffrey N. Martin, D. Bangsberg, J. Hahn, 2009, Journal of acquired immune deficiency syndromes.

Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach.

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.

Jeffrey N. Martin, T. Wrin, C. Petropoulos, 2004, The Journal of infectious diseases.

Evolution of Phenotypic Drug Susceptibility and Viral Replication Capacity during Long-Term Virologic Failure of Protease Inhibitor Therapy in Human Immunodeficiency Virus-Infected Adults

M. Segal, Jeffrey N. Martin, T. Wrin, 2002, Journal of Virology.

HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2016, Journal of acquired immune deficiency syndromes.

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy

M. Lederman, Jeffrey N. Martin, S. Shade, 2003, AIDS.

Point-of-Care C-Reactive Protein Testing to Facilitate Implementation of Isoniazid Preventive Therapy for People Living With HIV

Jeffrey N. Martin, D. Bangsberg, P. Nahid, 2014, Journal of acquired immune deficiency syndromes.

HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.

Jeffrey N. Martin, F. Hecht, J. McCune, 2011, Blood.

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

Richard D Moore, B. Lau, Jeffrey N. Martin, 2012, AIDS.

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

Sally S Bebawy, Richard D Moore, J. Goedert, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Substantial regional differences in human herpesvirus 8 seroprevalence in sub‐Saharan Africa: Insights on the origin of the “Kaposi's sarcoma belt”

Jeffrey N. Martin, C. Brander, C. Shiboski, 2010, International journal of cancer.

Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2015, The lancet. HIV.

Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic.

E. Vittinghoff, Jeffrey N. Martin, S. Buchbinder, 2002, JAMA.

HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda

M. Siedner, D. Kwon, D. Bangsberg, 2016, AIDS.

Use of Epidemiologically Well-Defined Subjects and Existing Immunofluorescence Assays To Calibrate a New Enzyme Immunoassay for Human Herpesvirus 8 Antibodies

Jeffrey N. Martin, D. Osmond, D. Kedes, 2000, Journal of Clinical Microbiology.

Implementation and Operational Research: Evaluating Outcomes of Patients Lost to Follow-up in a Large Comprehensive Care Treatment Program in Western Kenya

Elvin Geng, Paula Braitstein, Beth Rachlis, 2015, Journal of acquired immune deficiency syndromes.

Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2014, AIDS.

Disinhibition in Risky Sexual Behavior in Men, but Not Women, during Four Years of Antiretroviral Therapy in Rural, Southwestern Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2013, PloS one.

Mast Cell Activation and KSHV Infection in Kaposi Sarcoma

Jeffrey N. Martin, E. Cesarman, L. Ayers, 2018, Clinical Cancer Research.

D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda

Jeffrey N. Martin, M. Siedner, K. Williams, 2016, Journal of acquired immune deficiency syndromes.

Implementation of electronic medical records requires more than new software: Lessons on integrating and managing health technologies from Mbarara, Uganda.

Rebecca Weintraub, David R Bangsberg, Amy Madore, 2015, Healthcare.

Variations in Plasmacytoid Dendritic Cell (PDC) and Myeloid Dendritic Cell (MDC) Levels in HIV-Infected Subjects on and off Antiretroviral Therapy

Jeffrey N. Martin, B. Schmidt, J. Levy, 2006, Journal of Clinical Immunology.

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

J. Gerberding, Jeffrey N. Martin, F. Perdreau-Remington, 1999, The Journal of infectious diseases.

HIV-Induced Changes in T Cell Signaling Pathways1

Jeffrey N. Martin, J. McCune, Marc Schweneker, 2008, The Journal of Immunology.

Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment

Jeffrey N. Martin, D. Nixon, J. McCune, 2005, Journal of Virology.

Immunodominant HIV-Specific CD8+ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers

Jeffrey N. Martin, J. García, S. Deeks, 2010, Journal of Virology.

A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV.

Jeffrey N. Martin, M. Chesney, T. Coates, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Altered distribution of mucosal NK cells during HIV infection

Jeffrey N. Martin, G. Alter, D. Kwon, 2011, Mucosal Immunology.

Differential Expression of CD96 Surface Molecule Represents CD8+ T Cells with Dissimilar Effector Function during HIV-1 Infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2012, PloS one.

Retention Among North American HIV-Infected Persons in Clinical Care, 2000–2008

Richard D Moore, Jeffrey N. Martin, R. Hogg, 2013, Journal of acquired immune deficiency syndromes.

Longitudinal and quantitative fecal shedding dynamics of SARS-CoV-2, pepper mild mottle virus, and crAssphage

M. Peluso, R. Andino, Jeffrey N. Martin, 2023, mSphere.

Factors Associated With Delayed Hepatitis B Viral Suppression on Tenofovir Among Patients Coinfected With HBV-HIV in the CNICS Cohort

Richard D Moore, Jeffrey N. Martin, S. Boswell, 2014, Journal of acquired immune deficiency syndromes.

Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease

Jeffrey N. Martin, D. Glidden, H. Hatano, 2014, AIDS.

Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease

Jeffrey N. Martin, F. Hecht, J. McCune, 2010, PloS one.

Pulmonary hypertension in HIV-infected individuals.

A. Bolger, P. Hsue, Jeffrey N. Martin, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV

Jeffrey N. Martin, Min Li, S. Deeks, 2022, EBioMedicine.

Immunologic profiles distinguish aviremic HIV-infected adults

H. Hatano, F. Hecht, J. McCune, 2016, AIDS.

Higher CD27+CD8+ T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4+ T Cell Recovery in Treated HIV Infection

Jeffrey N. Martin, G. M. Ortiz, J. McCune, 2013, PloS one.

The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease

Jeffrey N. Martin, F. Hecht, P. Ganz, 2012, AIDS.

Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States

J. Kahn, Jeffrey N. Martin, M. Katz, 2004, AIDS.

Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior

J. Kahn, R. Kohn, Jeffrey N. Martin, 2004, AIDS.

Human Endogenous Retrovirus K106 (HERV-K106) Was Infectious after the Emergence of Anatomically Modern Humans

A. Jha, Jeffrey N. Martin, D. Nixon, 2011, PloS one.

Cross-Sectional Dating of Novel Haplotypes of HERV-K 113 and HERV-K 115 Indicate These Proviruses Originated in Africa before Homo sapiens

Emily C. Storm, A. Jha, Jeffrey N. Martin, 2009, Molecular biology and evolution.

Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection

T. Maurer, Jeffrey N. Martin, R. Effros, 2013, AIDS.

HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy

Jeffrey N. Martin, M. Shlipak, S. Deeks, 2009, AIDS.

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity

Jeffrey N. Martin, R. Koup, F. Hecht, 2020, JCI insight.

TCF-1 regulates the stem-like memory potential of HIV-specific CD8+ T cells in elite controllers

Jeffrey N. Martin, R. Koup, F. Hecht, 2020, bioRxiv.

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

Jeffrey N. Martin, R. Grant, S. Deeks, 2002, AIDS.

Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals

Jeffrey N. Martin, D. Havlir, D. Bangsberg, 2007 .

CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa

Richard D Moore, E. Vittinghoff, C. Yiannoutsos, 2015 .

Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2018, Annals of Internal Medicine.

Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2018, Journal of acquired immune deficiency syndromes.

MicroRNA biomarkers associated with type 1 myocardial infarction in HIV positive individuals.

Jeffrey N. Martin, K. Tanriverdi, R. Scherzer, 2019, AIDS.

Low Prevalence of Interferon-α Autoantibodies in People Experiencing Long COVID Symptoms

J. Derisi, M. Peluso, Jeffrey N. Martin, 2022, The Journal of infectious diseases.

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, medRxiv : the preprint server for health sciences.

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, Cell Reports.

Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, Open forum infectious diseases.

Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19

M. Peluso, Jeffrey N. Martin, Youngho Seo, 2023, medRxiv.

Early Biological Markers of Post-Acute Sequelae of SARS-CoV-2 Infection

Winslow, M. Peluso, Jeffrey N. Martin, 2023, medRxiv.

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

Michael I. Jordan, David E. Warren, David W. Chestek, 2023, medRxiv.

Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2

M. Peluso, Jeffrey N. Martin, J. Münch, 2023, bioRxiv.

Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients

Mark S. Anderson, J. Derisi, M. Peluso, 2023, medRxiv.

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection

M. Peluso, A. Sette, D. Weiskopf, 2022, AIDS.

Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies

M. Peluso, Jeffrey N. Martin, T. Henrich, 2022, Pathogens & immunity.

In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine

Jeffrey N. Martin, R. Paredes, D. Kuritzkes, 2008, Journal of Virology.

Cross-Sectional Dating of Novel of and Indicate These Proviruses Originated in Africa before Homo sapiens

Emily C. Storm, A. Jha, Jeffrey N. Martin, 2009 .

SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19

M. Peluso, Jeffrey N. Martin, T. Henrich, 2022, Annals of neurology.

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, Cells.

Comparison of Self-Reported Alcohol Consumption to Phosphatidylethanol Measurement among HIV-Infected Patients Initiating Antiretroviral Treatment in Southwestern Uganda

David R. Bangsberg, Jessica E. Haberer, Peter Hunt, 2014, PloS one.

Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

Jeffrey N. Martin, H. Hatano, P. Ganz, 2009, AIDS.

Dual Pressure from Antiretroviral Therapy and Cell-Mediated Immune Response on the Human Immunodeficiency Virus Type 1 Protease Gene

Jeffrey N. Martin, G. M. Ortiz, D. Nixon, 2003, Journal of Virology.

Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

Douglas S Kwon, Guoyan Zhao, Craig B Wilen, 2016, Cell host & microbe.

Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.

Jeffrey N. Martin, M. Siedner, D. Kwon, 2016, The Journal of infectious diseases.

Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.

Jeffrey N. Martin, P. Ganz, E. Secemsky, 2015, JACC. Heart failure.

Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers

Jeffrey N. Martin, H. Hatano, J. McCune, 2013, PLoS pathogens.

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

12, M. Peluso, Jeffrey N. Martin, 2021, medRxiv.

Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4+ T cell recovery after the initiation of antiretroviral therapy for HIV disease

Jeffrey N. Martin, G. M. Ortiz, J. McCune, 2014, AIDS Research and Therapy.

Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African Americans

J. Witte, Jeffrey N. Martin, J. McCune, 2011, Genes and Immunity.

GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2013, AIDS.

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection

J. Olgin, M. Pletcher, G. Marcus, 2023, Nature.

The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.

Jeffrey N. Martin, M. Schambelan, S. Deeks, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms

Jeffrey N. Martin, S. Little, M. Busch, 2017, Journal of acquired immune deficiency syndromes.

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics

Jeffrey N. Martin, S. Little, F. Hecht, 2016, AIDS.

Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository

Reshma Kassanjee, Alex Welte, Shelley N. Facente, 2014, AIDS.

Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa

C. Yiannoutsos, D. Bangsberg, R. Wood, 2014, AIDS.

U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008

Richard D Moore, Jeffrey N. Martin, R. Hogg, 2012, Annals of Internal Medicine.

Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?

Jeffrey N. Martin, L. Chinn, D. Kroetz, 2013, Pharmacogenetics and genomics.

Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection.

Jeffrey N. Martin, J. McCune, S. Deeks, 2019, Journal of acquired immune deficiency syndromes.

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

M. Lederman, Jeffrey N. Martin, C. Meinert, 2014, PLoS pathogens.

Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals

M. Lederman, Jeffrey N. Martin, F. Hecht, 2014, PLoS pathogens.

Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005‐2013

Jeffrey N. Martin, P. Harrigan, M. Siedner, 2018, AIDS patient care and STDs.

Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection

M. Carrington, M. John, S. Mallal, 2017, AIDS.

HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument

Jeffrey N. Martin, P. Harrigan, A. R. Mocello, 2015, Antimicrobial Agents and Chemotherapy.

Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda.

Jeffrey N. Martin, P. Harrigan, D. Knapp, 2014, AIDS research and human retroviruses.

HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection

J. Goedert, M. Carrington, B. Walker, 2017, Journal of Virology.

Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting

D. Bangsberg, A. Tsai, E. Frongillo, 2012, AIDS.

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection

M. Carrington, B. Walker, M. John, 2017, Journal of Virology.

Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.

Jeffrey N. Martin, P. Rosenthal, C. Brander, 2009, The Journal of infectious diseases.

Impact of pre-existing chronic viral infection and reactivation on the development of long COVID.

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, The Journal of clinical investigation.

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, JCI insight.

Diagnosis and epidemiology of human herpesvirus 8 infection.

Jeffrey N. Martin, Jeffrey N. Martin, 2003, Seminars in hematology.

Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.

C. Long, M. Peluso, D. Glidden, 2023, The Journal of infectious diseases.

Chronic viral coinfections differentially affect the likelihood of developing long COVID

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2023, The Journal of Clinical Investigation.

A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection

Jeffrey N. Martin, H. Hatano, E. Sinclair, 2012, Journal of acquired immune deficiency syndromes.

Use of Saliva as a Lubricant in Anal Sexual Practices Among Homosexual Men

D. Osmond, L. Butler, A. Jones, 2009, Journal of acquired immune deficiency syndromes.

Diminishing Availability of Publicly Funded Slots for Antiretroviral Initiation among HIV-Infected ART-Eligible Patients in Uganda

Jeffrey N. Martin, D. Bangsberg, E. Geng, 2010, PloS one.

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19

M. Peluso, Jeffrey N. Martin, T. Henrich, 2022, Annals of clinical and translational neurology.

HIV antibody characterization as a method to quantify reservoir size during curative interventions.

Jeffrey N. Martin, J. Kovacs, S. Deeks, 2014, The Journal of infectious diseases.

Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda

M. Huchko, F. Mubiru, M. Swanson, 2019, Infectious Agents and Cancer.

Reduced Exercise Capacity, Chronotropic Incompetence, Inflammation and Symptoms in Post-Acute COVID-19

C. Long, M. Peluso, D. Glidden, 2022, medRxiv.

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

J. Kahn, Jeffrey N. Martin, R. Grant, 2001, The Journal of infectious diseases.

Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.

J. Kahn, Jeffrey N. Martin, M. Katz, 2004, Archives of internal medicine.

Decline in HIV infectivity following the introduction of highly active antiretroviral therapy

Jeffrey N. Martin, R. Grant, D. Osmond, 2003, AIDS.

Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection

M. Peluso, Jeffrey N. Martin, D. Glidden, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Optimizing Network Connectivity for Mobile Health Technologies in sub-Saharan Africa

Mark J. Siedner, Alexander Lankowski, Derrick Musinga, 2012, PloS one.

Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression

Jeffrey N. Martin, M. Siedner, K. Williams, 2018, Journal of acquired immune deficiency syndromes.

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

Jeffrey N. Martin, H. Hatano, E. Delwart, 2010, AIDS.

Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor

T. Ndung’u, Jeffrey N. Martin, F. Hecht, 2015, Proceedings of the National Academy of Sciences.

Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.

David W. Williamson, Jeffrey N. Martin, P. Harrigan, 2006, The Journal of infectious diseases.

Practice of Epidemiology Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework : Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy

S. Cole, B. Lau, Jeffrey N. Martin, 2015 .

Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda.

Jeffrey N. Martin, P. Tien, D. Bangsberg, 2011, AIDS research and human retroviruses.

Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells

J. Goedert, M. Carrington, B. Walker, 2018, Science.

The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.

Jeffrey N. Martin, J. McCune, D. Bangsberg, 2014, The Journal of infectious diseases.

CD56negCD16+ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2013, Retrovirology.

CD 56 negCD 16 + NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

CD56 neg CD16 + NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America

Sally S Bebawy, Richard D Moore, J. Goedert, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High Levels of Antiretroviral Use and Viral Suppression Among Persons in HIV Care in the United States, 2010

Richard D Moore, M. Golden, Jeffrey N. Martin, 2013, Journal of acquired immune deficiency syndromes.

HIV infection is associated with decreased thrombin generation.

Jeffrey N. Martin, C. Grunfeld, S. Deeks, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis

Jeffrey N. Martin, B. Autran, J. McCune, 2012, AIDS.

Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART

S. Mallal, Jeffrey N. Martin, J. Schiffer, 2021, PLoS pathogens.

Super learner analysis of real‐time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non‐differentiated care approaches for persons living with HIV in rural Uganda

M. Petersen, Jeffrey N. Martin, D. Bangsberg, 2020, Journal of the International AIDS Society.

Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen.

Jeffrey N. Martin, N. Parkin, S. Deeks, 2004, AIDS.

High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against M. tuberculosis antigen

J. Ernst, S. Deeks, F. Aweeka, 2023, bioRxiv.

AIDS Alters the Commensal Plasma Virome

Jeffrey N. Martin, E. Delwart, D. Bangsberg, 2013, Journal of Virology.

Failure to Initiate Antiretroviral Therapy, Loss to Follow-up and Mortality Among HIV-Infected Patients During the Pre-ART Period in Uganda

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2013, Journal of acquired immune deficiency syndromes.

Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2017, AIDS.

A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma

C. Yiannoutsos, A. Semeere, T. Maurer, 2016, Cancer medicine.

Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings

A. Semeere, Jeffrey N. Martin, Jeffrey N Martin, 2012, Current opinion in oncology.

Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, medRxiv.

Sampling-Based Approaches to Improve Estimation of Mortality among Patient Dropouts: Experience from a Large PEPFAR-Funded Program in Western Kenya

C. Yiannoutsos, Jeffrey N. Martin, C. Frangakis, 2008, PloS one.

Estimation of Mortality among HIV-infected people on antiretroviral therapy treatment in east Africa: a sampling based approach in an observational, multisite, cohort study.

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2015, The lancet. HIV.

A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5

F. Bushman, R. Doms, Jeffrey N. Martin, 2010, Journal of Virology.

Internalized Stigma, Social Distance, and Disclosure of HIV Seropositivity in Rural Uganda

Alexander C. Tsai, Elias Kumbakumba, Conrad Muzoora, 2013, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection

Jeffrey N. Martin, M. Busch, S. Deeks, 2012, PloS one.

Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons.

Jeffrey N. Martin, S. Deeks, K. Mulligan, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.

F. Pereyra, B. Walker, R. Kaul, 2011, Blood.

Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV‐Infected Adults

Jeffrey N. Martin, S. Deeks, R. Scherzer, 2019, Journal of the American Heart Association.

Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2014, PLoS neglected tropical diseases.

Real-Time Adherence Monitoring for HIV Antiretroviral Therapy

Nneka Emenyonu, David R. Bangsberg, Jessica E. Haberer, 2010, AIDS and Behavior.

The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults

Jeffrey N. Martin, S. Deeks, T. Fujiwara, 2012, Journal of acquired immune deficiency syndromes.

Rethinking the “Pre” in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs

Nneka Emenyonu, Elvin Geng, Alexander C. Tsai, 2012, PloS one.

Isotype Diversification against HIV-1 p 24 Associated with Greater Opsonophagocytic IgG Antibody Responses Reactive − Plasmacytoid Dendritic Cell Viremic HIV Controllers Exhibit High

Jeffrey N. Martin, Sônia, S. Deeks, 2015 .

Discordance Between Peripheral and Colonic Markers of Inflammation During Suppressive ART

M. J. Broadhurst, M. Lederman, P. Loke, 2014, Journal of acquired immune deficiency syndromes.

Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection

Jeffrey N. Martin, M. Robb, G. Alter, 2017, Journal of Virology.

HIV and Premature Aging: A Field Still in Its Infancy

P. Volberding, Jeffrey N. Martin, Jeffrey N. Martin, 2010, Annals of Internal Medicine.

Composition and Function of T Cell Subpopulations Are Slow to Change Despite Effective Antiretroviral Treatment of HIV Disease

Jeffrey N. Martin, D. Nixon, J. McCune, 2014, PloS one.

Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa

T. Maurer, Jeffrey N. Martin, K. Wools-Kaloustian, 2016, Journal of acquired immune deficiency syndromes.

Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa.

Jeffrey N. Martin, D. Glidden, E. Geng, 2008, JAMA.

CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2014, AIDS.

Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression

R. Greenblatt, K. Anastos, M. Young, 2017, Journal of Virology.

Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers

Jeffrey N. Martin, H. Hatano, E. Sinclair, 2013, AIDS.

HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses

Jeffrey N. Martin, J. García, S. Deeks, 2010, Journal of Virology.

Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects

Jeffrey N. Martin, L. Montaner, E. Papasavvas, 2012, Antiviral therapy.

Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy

Jeffrey N. Martin, C. Petropoulos, H. Hatano, 2010, Journal of acquired immune deficiency syndromes.

Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda

M. Carrington, Jeffrey N. Martin, P. Harrigan, 2021, AIDS.

Abstract 2287: Diastolic Dysfunction is Common in Asymptomatic HIV Patients

Jeffrey N. Martin, A. Bolger, D. Waters, 2007 .

Indoleamine 2,3 dioxygenase, age, and immune activation in people living with HIV

Jeffrey N. Martin, M. Saag, A. Mellor, 2021, Journal of Investigative Medicine.

Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers

Jeffrey N. Martin, M. Robb, G. Alter, 2017, Journal of Virology.

Elevated Plasma von Willebrand Factor Levels Are Associated With Subsequent Ischemic Stroke in Persons With Treated HIV Infection

Jeffrey N. Martin, M. Wurfel, C. Marra, 2021, Open forum infectious diseases.

Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy

M. Lederman, Jeffrey N. Martin, K. Williams, 2017, The Journal of infectious diseases.

Longitudinal and Quantitative Fecal Shedding Dynamics of SARS-CoV-2, Pepper Mild Mottle Virus and CrAssphage

M. Peluso, R. Andino, Jeffrey N. Martin, 2023, medRxiv.

Plasma components affect accuracy of circulating cancer-related microRNA quantitation.

A. Gilman‐Sachs, S. Linnstaedt, K. Beaman, 2012, The Journal of molecular diagnostics : JMD.

Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus–Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study

M. Saag, E. Geng, C. Hurt, 2019, Open forum infectious diseases.

Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda

Jeffrey N. Martin, P. Harrigan, A. R. Mocello, 2016, AIDS.

Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2017, Journal of acquired immune deficiency syndromes.